ETHEMA HEALTH Posts Widening Loss Amid Zero Revenue, Eyes Expansion

TL;DR

GRST is a speculative bet on a turnaround, with zero revenue and widening losses making it a high-risk play for traders.

AI Summary

ETHEMA HEALTH Corp (GRST) reported a net loss of $1,000,000 for the fiscal year ended December 31, 2024, a significant increase from the $500,000 net loss in 2023. Revenue remained flat at $0 for both 2024 and 2023, indicating no operational income. The company's strategic outlook is focused on securing new business opportunities, as evidenced by the lease agreements for new premises in West Palm Beach, Florida, signed on March 21, 2024, and May 15, 2024. Key business changes include the acquisition of leasehold improvements totaling $250,000 in 2024, alongside new furniture and fixtures valued at $100,000 and vehicles at $50,000. Risks include the company's continued reliance on external financing due to persistent net losses and zero revenue, as well as the potential for further dilution of common stock, which stood at $10,000,000 in 2024. The company's retained earnings show a deficit of $15,000,000 as of December 31, 2024, worsening from a $14,000,000 deficit in 2023.

Why It Matters

ETHEMA HEALTH's continued lack of revenue and increasing net losses, reaching $1,000,000 in 2024, signal significant operational challenges for investors. The company's strategy to lease new premises in West Palm Beach, Florida, on March 21, 2024, and May 15, 2024, suggests an attempt to pivot or expand, but without clear revenue generation, this could further strain resources. For employees, the lack of a stable revenue stream raises concerns about long-term job security, while customers are non-existent given the zero revenue. In a competitive healthcare services market, GRST's current financial state makes it a non-factor, highlighting the difficulty for new entrants without substantial capital or a viable business model.

Risk Assessment

Risk Level: high — The risk level is high due to ETHEMA HEALTH Corp's reported net loss of $1,000,000 in 2024 and $500,000 in 2023, coupled with zero revenue for both periods. This indicates a complete lack of operational income and a reliance on financing, as evidenced by the $10,000,000 in common stock and $15,000,000 accumulated deficit in retained earnings as of December 31, 2024.

Analyst Insight

Investors should avoid ETHEMA HEALTH Corp (GRST) given its zero revenue and consistent net losses. The company's current financial state suggests it is not a viable investment until a clear, revenue-generating business model is established and demonstrated.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

-$1,000,000

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

0.0%

Key Numbers

• $1.0M — Net Loss (Increased from $0.5M in 2023, indicating worsening financial performance.)
• $0 — Revenue (No operational income generated in both 2024 and 2023.)
• $15.0M — Retained Earnings Deficit (Worsened from $14.0M in 2023, reflecting accumulated losses.)
• $250K — Leasehold Improvements (New assets acquired in 2024, indicating investment in new premises.)
• $10.0M — Common Stock (Represents capital raised, potentially through dilution, to fund operations.)

Key Players & Entities

• ETHEMA HEALTH Corp (company) — filer of 10-K
• GRST (company) — ticker symbol
• $1,000,000 (dollar_amount) — net loss for 2024
• $500,000 (dollar_amount) — net loss for 2023
• West Palm Beach, Florida (location) — location of new leased premises
• March 21, 2024 (date) — date of lease agreement
• May 15, 2024 (date) — date of lease agreement
• $250,000 (dollar_amount) — leasehold improvements in 2024
• $10,000,000 (dollar_amount) — common stock value in 2024
• $15,000,000 (dollar_amount) — retained earnings deficit in 2024

FAQ

Risk Factors

• Persistent Net Losses and Zero Revenue [high — financial]: ETHEMA HEALTH Corp reported a net loss of $1,000,000 for fiscal year 2024, an increase from $500,000 in 2023. Revenue remained at $0 for both years. This lack of operational income necessitates continued reliance on external financing.
• Deteriorating Retained Earnings [high — financial]: The company's retained earnings deficit widened to $15,000,000 in 2024 from $14,000,000 in 2023. This indicates a significant accumulation of losses over time, impacting the company's equity base.
• Potential for Stock Dilution [medium — financial]: Common stock increased to $10,000,000 in 2024. Given the lack of revenue and ongoing losses, this increase likely stems from the issuance of new shares to secure funding, posing a risk of significant dilution for existing shareholders.
• Dependence on New Business Opportunities [medium — operational]: The company's strategic focus is on securing new business opportunities. The recent lease agreements for new premises in West Palm Beach, Florida, signed on March 21, 2024, and May 15, 2024, represent investments towards this goal, but their success is not guaranteed.

Industry Context

ETHEMA HEALTH Corp operates within the healthcare services sector, specifically general medical and surgical hospitals. This industry is characterized by high regulatory oversight, significant capital investment requirements, and intense competition. Trends include a growing demand for specialized healthcare services and increasing adoption of technology, alongside pressures to control costs and improve patient outcomes.

Regulatory Implications

As a healthcare provider, ETHEMA HEALTH Corp is subject to stringent regulations from bodies like the FDA and CMS, covering patient care, data privacy (HIPAA), and billing practices. Non-compliance can lead to substantial fines, operational disruptions, and reputational damage.

What Investors Should Do

1. Monitor progress on securing new business opportunities.
2. Scrutinize future financing activities.
3. Evaluate the return on investment for new assets.

Key Dates

• 2024-03-21: Lease agreement for new premises signed — Indicates expansion and investment in new operational capacity, signaling a strategic move to secure future business.
• 2024-05-15: Second lease agreement for new premises signed — Further reinforces the company's commitment to expanding its physical footprint and operational capabilities in West Palm Beach.
• 2024-12-31: Fiscal year end — Reporting period for the 10-K, showing a net loss of $1,000,000 and a retained earnings deficit of $15,000,000.

Glossary

Retained Earnings

The cumulative amount of net income that a company has retained over its life, after paying out dividends. (A negative retained earnings balance (deficit) indicates that the company has accumulated more losses than profits since its inception.)

Leasehold Improvements

Costs incurred to improve a leased property to suit the tenant's needs. These are typically amortized over the shorter of the lease term or the useful life of the improvement. (The $250,000 investment in leasehold improvements signifies the company's commitment to its new premises and future operations.)

Common Stock

Represents ownership in a corporation and is the most basic form of corporate ownership. (The $10,000,000 value of common stock may reflect capital raised, potentially through share issuances, to fund operations given the lack of revenue.)

Year-Over-Year Comparison

ETHEMA HEALTH Corp's financial performance has deteriorated significantly compared to the prior year. The net loss has doubled from $500,000 in 2023 to $1,000,000 in 2024, while revenue has remained stagnant at $0. The retained earnings deficit has also widened by $1,000,000 to $15,000,000. New risks have emerged related to the company's aggressive investment in new premises and assets without any corresponding revenue generation, increasing reliance on external financing and potential for dilution.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on May 23, 2025 regarding ETHEMA HEALTH Corp (GRST).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR